期刊文献+

耻垢分枝杆菌与卡介苗作为载体在鼠结核病治疗中的作用比较 被引量:3

Comparative Study on Roles of Mycobacterium smegmatis and BCG as Vectors in Treatment of Tuberculosis in Mouse Model
下载PDF
导出
摘要 目的比较耻垢分枝杆菌(MS)与卡介苗(BCG)作为载体在鼠结核病治疗中的作用。方法分别以不同剂量的MS和BCG免疫BALB/c小鼠,观察二者的致病作用。以结核分枝杆菌H37Rv感染BALB/c小鼠4周后,分别用生理盐水、MS、GLS/IL-12、重组MS、BCG及GLS/IL-12重组BCG治疗6次,于第6次治疗后7d处死小鼠,检测肺、脾荷菌量、血清IL-12和IFN-γ水平、脾淋巴细胞IFN-γ和TNF-α的水平及肺、脾组织中颗粒溶素表达,并观察小鼠肺组织病理改变。结果重组MS和重组BCG组器官荷菌量明显低于MS和BCG组;重组MS和重组BCG组血清IL-12和IFN-γ水平明显高于MS和BCG组,MS和BCG组明显高于生理盐水组;重组MS和重组BCG组脾淋巴细胞IFN-γ和TNF-α的水平明显高于其他组;MS与BCG组比较,重组MS与重组BCG比较,荷菌量、病理变化、肺、脾中的IL-12和IFN-γ水平差异均无显著意义;淋巴细胞中的IFN-γ和TNF-α水平,MS与BCG组差异有显著意义,而重组MS与重组BCG组差异无显著意义;重组MS和重组BCG组在肺、脾中均有颗粒溶素表达;MS所致病变比相同剂量BCG轻。结论MS与BCG一样,可将要表达的基因靶向递送到相应的组织,并诱导特异性细胞免疫,同时其在体内的副作用低于BCG,因此可作为良好的有机载体。 Objective To explore the roles of Mycobacterium smegmatis (MS) and BCG as vectors in treatment of tuberculosis in mouse model. Methods Infect BALB/c mice with MS and BCG at various dosages and observe the pathogenic effects. Divide the BALB/c mice 4 weeks after infection with Mycobacterium tuberculosis H37Rv strain into 5 groups and treat with physiological saline, MS, granulysin (GLS)/IL-12 recombinant with MS (recombinant MS), BCG and GLS/IL-12 recombinant with BCG (recombinant BCG) for 6 times respectively, Kill the mice 7 d after the 6th treatment and determine the bacterial loading quantity and expression level of GLS in lung and spleen, IL-12 and IFN-γ in sera as well as IFN-γ and TNF-α in splenic lymphocytes, and observe the pathological change of lung tissue. Results The pathological change caused by BCG was severer than that by MS at the same dosage. The bacterial loading quantities in lungs and spleens of mice in recombinant MS and recombinant BCG groups were signifi- cantly lower, while serum IL-12 and IFN-γ levels were significantly higher than those in MS and BCG groups. However, the serum IL-12 and IFN-γlevels of mice in MS and BCG groups were significantly higher than those in physiological saline group. The IFN-γ and TNF-α levels in splenic lymphocytes of mice in recombinant MS and recombinant BCG groups were significantly higher than those in other groups. No significant difference were observed in the bacterial loading quantity and IL-12 and IFN-γ levels in lung and spleen as well as pathological change in lung of mice in MS and BCG groups, or in recombinant MS and BCG groups. The IFN-γand TNF-α levels in splenic lymphocytes of mice showed significant difference in MS and BCG groups, while showed no significant difference in recombinant MS and recombinant BCG groups. The expression of GLS was observed in the lung and spleen of mice in recombinant MS and recombinant BCG groups. Conclusion Like BCG, MS could deliver the gene to be expressed to the target tissue and induce specific cellular immunity. However, the adverse reaction induced by MS was mild as compared with that by BCG. It proved that MS might be used as a satisfactory organic vector.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第7期545-548,共4页 Chinese Journal of Biologicals
基金 国家自然科学基金资助项目(NO.30771922) 重庆市自然科学基金重点资助项目(NO.2007BA5013)
关键词 耻垢分枝杆菌 卡介苗 载体 颗粒溶素 结核病 Mycobacterium smegmatis BCG Vector Granulysin Tuberculosis
  • 相关文献

参考文献11

  • 1Thoma-Uszynski S, Stenger S, Takeuchi O, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science, 2001, 291(5508): 1544-1547.
  • 2杨春,何永林,伊正君,李俊明,李娜,朱道银.GLS/IL-12重组耻垢分枝杆菌的构建及其在小鼠体内的表达[J].免疫学杂志,2007,23(1):34-37. 被引量:4
  • 3杨春,张黎,伊正君,何永林,王渝伟,李娜,徐蕾,朱道银.GLS/IL-12重组BCG的构建及其对小鼠结核病疗效的研究[J].中国人兽共患病学报,2007,23(8):774-778. 被引量:3
  • 4Divison of Microbiology & Infectious Diseases, Microbial Research. Global Health.Tuberculosis Vaccines: State of the Science[EB/OL] http://www. niaid. nih. gov / dmid / tuberculosis / tbvaccine. htm 2001-1-52007-4-1.
  • 5Young SL, Murphy M, Zhu XW, et al. Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapy. Int J Cancer, 2004, 112 (4): 653-660.
  • 6Yi Z, Fu Y, Yang C, et al. Recombinant M smegmatis vaccine targeted delivering IL-12/GLS into macrophage can induce specific cellular immunity against M.tuberculosis in BALB / c mice. Vaccine, 2007, 25(4): 638-648.
  • 7徐苗,陈保文,沈小兵,苏城,罗永艾,王国治.耻垢分枝杆菌作为免疫调节剂的研究[J].中华微生物学和免疫学杂志,2005,25(9):752-755. 被引量:11
  • 8徐苗,陈保文,沈小兵,苏城,罗永艾,王国治.耻垢分枝杆菌疫苗对小鼠细胞因子产生及Th1/Th2应答的影响[J].中华结核和呼吸杂志,2005,28(11):781-784. 被引量:9
  • 9Cayabyab M J, Hovav AH, Hsu T, et al. Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env. J Virol, 2006, 80(4): 1645-1652.
  • 10Yu JS, Peacock JM, Vanleeuween S, et al. Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis. Clin Vaccine Immunol, 2006, 13( 11 ): 1024-1211.

二级参考文献38

  • 1李洪涛,张天托.活动性肺结核与细胞因子[J].医学综述,2004,10(7):424-426. 被引量:1
  • 2江山,朱道银,骆旭东,陈全,蒋英.结核分枝杆菌Ag85B与IL-12基因真核共表达质粒的构建及表达[J].细胞与分子免疫学杂志,2004,20(6):664-666. 被引量:4
  • 3伊正君,朱道银,陈全,李俊明,曾伟.人颗粒溶素与小鼠单链IL-12真核共表达质粒的构建及其在RAW264.7细胞中的表达[J].中国人兽共患病杂志,2005,21(11):936-939. 被引量:9
  • 4Filion MC, Filion B, Reader S, et al. Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex. Cancer Immunol Immunother, 2000, 49(6): 325-334.
  • 5Labidi AH, Estes RC, David HL, et al. Mycobacterium recombinant vaccines. Tunis Med, 2001, 79(2): 65-81.
  • 6Faldt J, Dahlgren C, Ridell M. Difference in neutrophil cytokine production induced by pathogenic and non-pathogenic mycobacteria. APMIS,2002, 110(9): 593-600.
  • 7Rook GA, Seah G, Ustianowski A. M. tuberculosis: immunology and vaccination. Eur Respir J, 2001, 17(3): 537-557.
  • 8Jo EK, Park JK, Dockrell HN. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Diseases,2003, 16(3): 205-210.
  • 9Bosio CM, Orme IM. Effective, nonsensitizing vaccination with culture filtrate proteins against virulent Mycobacterium bovis infections in mice.Infect Immun, 1998, 66(10): 5048-5051.
  • 10Mosmann TR,Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today,1996,17:138-146.

共引文献20

同被引文献19

  • 1徐苗,陈保文,沈小兵,苏城,罗永艾,王国治.耻垢分枝杆菌疫苗对小鼠细胞因子产生及Th1/Th2应答的影响[J].中华结核和呼吸杂志,2005,28(11):781-784. 被引量:9
  • 2徐苗,罗永艾,陈保文,沈小兵,苏城,王国治.无细胞耻垢分枝杆菌疫苗对结核杆菌感染者的预防作用研究[J].药品评价,2006,3(2):102-104. 被引量:6
  • 3高红刚,张佃波,卞传秀,刘克义.弓形虫重组耻垢分枝杆菌M.S-P30-ROP2载体活疫苗构建及鉴定[J].中国热带医学,2007,7(4):489-491. 被引量:10
  • 4Harth G, Maslesa-Galic S, Horwitz MA. A two-plasmid system for stable, selective-pressure-independent expression of multiple extracellular proteins in mycabacteria [J], Microbiology, 2004, 150 (Pt 7): 2143-2151.
  • 5Cayabyab MJ, Hovav AH, Hsu T, et al. Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env [J]. J Virol, 2006, 80 (4): 1645-1652.
  • 6Yu JS, Peacock JW, Vanleeuwen S, et al. Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis [J]. Clin Vaccine Immunol, 2006, 13 (11): 1204-1211.
  • 7DasGupta SK, Jain S, Kaushal D, etal. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines [J]. Biochem Biophys Res Commun, 1998, 246 (3): 797-804.
  • 8Lim EM, Rauzier J, Timm J, et al. Identification of mycobacterium tuberculosis DNA sequences encoding exported proteins by using phoA gene fusions [J]. J Bacteriol, 1995, 177 (1): 59-65.
  • 9Sirakova TD, Fitzmaurice AM, Kolattukudy P. Regulation of expression of mas and fadD28, two genes involved in production of dimycocerosyl phthiocerol, a virulence factor of mycobacterium tuberculosis [J]. J Baeteriol, 2002, 184(24): 6796-6802.
  • 10刘畅,樊明文.针对细菌感染的治疗性疫苗研究进展[J].中国生物制品学杂志,2008,21(5):445-448. 被引量:4

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部